Clinical Trial Design, Precision Medicine Added To CDRH Science Priorities
Executive Summary
US FDA's device center issued its third annual regulatory science priorities list, adding emphasis on clinical trial designs, and precision medicine and biomarkers, while dropping human-factors engineering from the list.